HALO - Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company. The Company is engaged in the development and commercialization of recombinant human enzymes, which either transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefit. Its existing products and its products under developme","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"